Bristol-Myers Squibb to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 06 2020 - 4:16PM
Business Wire
Bristol-Myers Squibb Company (NYSE: BMY) will present at the
J.P. Morgan 38th Annual Healthcare Conference on Monday, January
13, 2020 in San Francisco. Giovanni Caforio, chairman and chief
executive officer, will make a formal presentation about the
company at 7:30 a.m. PT (10:30 a.m. ET).
Investors and the general public are invited to listen to a live
webcast of the presentation at http://investor.bms.com. Materials
related to the presentation will be available at the same website
at the start of the live webcast. An archived edition of the
presentation will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
Celgene and Juno Therapeutics are wholly owned subsidiaries of
Bristol-Myers Squibb Company. In certain countries outside the
U.S., due to local laws, Celgene and Juno Therapeutics are referred
to as, Celgene, a Bristol-Myers Squibb company and Juno
Therapeutics, a Bristol-Myers Squibb company.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200106005136/en/
Media: media@bms.com 609-252-3345
Investors: Tim Power, 609-252-7509, timothy.power@bms.com Nina
Goworek, 908-673-9711, ngoworek@celgene.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024